These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36409221)

  • 21. Interventions for visual field defects in people with stroke.
    Pollock A; Hazelton C; Rowe FJ; Jonuscheit S; Kernohan A; Angilley J; Henderson CA; Langhorne P; Campbell P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD008388. PubMed ID: 31120142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Daily Physical Activity across the Spectrum of Visual Field Damage in Glaucoma Patients.
    E JY; Schrack JA; Mihailovic A; Wanigatunga AA; West SK; Friedman DS; Gitlin LN; Li T; Ramulu PY
    Ophthalmology; 2021 Jan; 128(1):70-77. PubMed ID: 32615202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-reported vision-related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma.
    Cheng HC; Guo CY; Chen MJ; Ko YC; Huang N; Liu CJ
    JAMA Ophthalmol; 2015 Mar; 133(3):269-75. PubMed ID: 25429608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wayfinding and Glaucoma: A Virtual Reality Experiment.
    Daga FB; Macagno E; Stevenson C; Elhosseiny A; Diniz-Filho A; Boer ER; Schulze J; Medeiros FA
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3343-3349. PubMed ID: 28687845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Greater Physical Activity Is Associated with Slower Visual Field Loss in Glaucoma.
    Lee MJ; Wang J; Friedman DS; Boland MV; De Moraes CG; Ramulu PY
    Ophthalmology; 2019 Jul; 126(7):958-964. PubMed ID: 30315900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning to read vertical text in peripheral vision.
    Subramanian A; Legge GE; Wagoner GH; Yu D
    Optom Vis Sci; 2014 Sep; 91(9):1097-105. PubMed ID: 25062130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vision rehabilitation in glaucoma patients.
    Shi A; Salim S
    Curr Opin Ophthalmol; 2023 Mar; 34(2):109-115. PubMed ID: 36718681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Central and Peripheral Visual Field Concordance in Glaucoma.
    Odden JL; Mihailovic A; Boland MV; Friedman DS; West SK; Ramulu PY
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2797-804. PubMed ID: 27214688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Important areas of the central binocular visual field for daily functioning in the visually impaired.
    Tabrett DR; Latham K
    Ophthalmic Physiol Opt; 2012 Mar; 32(2):156-63. PubMed ID: 22304533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for visual field defects in patients with stroke.
    Pollock A; Hazelton C; Henderson CA; Angilley J; Dhillon B; Langhorne P; Livingstone K; Munro FA; Orr H; Rowe FJ; Shahani U
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008388. PubMed ID: 21975779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How does glaucoma look?: patient perception of visual field loss.
    Crabb DP; Smith ND; Glen FC; Burton R; Garway-Heath DF
    Ophthalmology; 2013 Jun; 120(6):1120-6. PubMed ID: 23415421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of Glaucoma Patients Attending a Vision Rehabilitation Service.
    Kaleem MA; Rajjoub R; Schiefer C; Wall J; Applegate C; Tian J; Sunness JS
    Ophthalmol Glaucoma; 2021; 4(6):638-645. PubMed ID: 33722789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for first presentation of glaucoma with significant visual field loss.
    Deva NC; Insull E; Gamble G; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2008 Apr; 36(3):217-21. PubMed ID: 18412589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring Disability in Glaucoma.
    Sotimehin AE; Ramulu PY
    J Glaucoma; 2018 Nov; 27(11):939-949. PubMed ID: 30161076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glaucoma and disability: which tasks are affected, and at what stage of disease?
    Ramulu P
    Curr Opin Ophthalmol; 2009 Mar; 20(2):92-8. PubMed ID: 19240541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive Visual Field Loss and Subsequent Quality of Life Outcomes in Glaucoma.
    Moghimi S; Kamalipour A; Nishida T; Zangwill L; Fazio M; Girkin CA; Liebmann JM; Weinreb RN
    Am J Ophthalmol; 2023 Aug; 252():295-305. PubMed ID: 37142176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.
    Boodhna T; Crabb DP
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):225-30. PubMed ID: 25545852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.
    Garg A; De Moraes CG; Cioffi GA; Girkin CA; Medeiros FA; Weinreb RN; Zangwill LM; Liebmann JM
    Am J Ophthalmol; 2018 Mar; 187():92-98. PubMed ID: 29317211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glaucomatous visual field loss associated with less travel from home.
    Ramulu PY; Hochberg C; Maul EA; Chan ES; Ferrucci L; Friedman DS
    Optom Vis Sci; 2014 Feb; 91(2):187-93. PubMed ID: 24374635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study.
    McKean-Cowdin R; Wang Y; Wu J; Azen SP; Varma R;
    Ophthalmology; 2008 Jun; 115(6):941-948.e1. PubMed ID: 17997485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.